Susan M. Kaup, PhD, ISMPP CMPPTM; Michelle Daniels, MD, ISMPP CMPPTM; Brian Szente, PhD; inScience Communications, Springer Healthcare, Philadelphia, PA, USA Several guidelines have been instrumental for implementing practices to fairly credit contributors to the...
Heidi A. Schreiber, PhD, and Todd Parker, PhD, ISMPP CMPP™; MedThink SciCom, Cary, NC, USA In today’s world, the need for pharmaceutical companies to quickly publish and disseminate their data is higher than ever. And, although fast is fine, accuracy is everything. As...
Chris Winchester, DPhil, Oxford PharmaGenesis, Oxford, UK Do pharmaceutical companies have a role in helping advance the publication of science? This was the question posed by Richard Smith, Former Editor of The BMJ and now Chairman for the Board of Directors of...
Rebecca McCracken, MSPH, ISMPP CMPP™, the Lockwood Group, Stamford, CT, USA; Kelly Mayer, BSc, the Lockwood Group, Stamford, CT, USA This article is part of the Medical Publications 101 article series, which serves as an introduction to various topics that are...
Ellen Baum, PhD, Janssen Research & Development, LLC Predatory conferences are “for-profit, low-quality academic meetings that exploit researchers’ need to share and publish their research” (1) and have been variously described as “questionable” (2), “fraudulent,...
Morgan C. Hill, PhD, ISMPP CMPP™, Infusion, Ashfield Healthcare Communications, part of UDG Healthcare, Middletown, CT, USA; Kenneth Pomerantz, PhD, Alexion Pharmaceuticals, Inc., New Haven, CT, USA; Michael Mandola, PhD, ISMPP CMPP™, Bristol-Myers Squibb, Princeton,...
